• Je něco špatně v tomto záznamu ?

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

N. Groot, N. de Graeff, T. Avcin, B. Bader-Meunier, P. Brogan, P. Dolezalova, B. Feldman, I. Kone-Paut, P. Lahdenne, SD. Marks, L. McCann, S. Ozen, C. Pilkington, A. Ravelli, AV. Royen-Kerkhof, Y. Uziel, B. Vastert, N. Wulffraat, S. Kamphuis, MW....

. 2017 ; 76 (11) : 1788-1796. [pub] 20170619

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016537
E-zdroje Online Plný text

NLK ProQuest Central od 1939-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest) od 1939-01-01 do Před 6 měsíci

Odkazy

PubMed 28630236
DOI 10.1136/annrheumdis-2016-210960
Knihovny.cz E-zdroje

Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially life-threatening autoimmune disorder with significant associated morbidity. Evidence-based guidelines are sparse and management is often based on clinical expertise. SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) was launched to optimise and disseminate management regimens for children and young adults with rheumatic diseases like cSLE. Here, we provide evidence-based recommendations for diagnosis and treatment of cSLE. In view of extent and complexity of cSLE and its various manifestations, recommendations for lupus nephritis and antiphospholipid syndrome will be published separately. Recommendations were generated using the EULAR (European League Against Rheumatism) standard operating procedure. An expert committee consisting of paediatric rheumatologists and representation of paediatric nephrology from across Europe discussed evidence-based recommendations during two consensus meetings. Recommendations were accepted if >80% agreement was reached. A total of 25 recommendations regarding key approaches to diagnosis and treatment of cSLE were made. The recommendations include 11 on diagnosis, 9 on disease monitoring and 5 on general treatment. Topics included: appropriate use of SLE classification criteria, disease activity and damage indices; adequate assessment of autoantibody profiles; secondary macrophage activation syndrome; use of hydroxychloroquine and corticosteroid-sparing regimens; and the importance of addressing poor adherence. Ten recommendations were accepted regarding general diagnostic strategies and treatment indications of neuropsychiatric cSLE. The SHARE recommendations for cSLE and neuropsychiatric manifestations of cSLE have been formulated by an evidence-based consensus process to support uniform, high-quality standards of care for children with cSLE.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016537
003      
CZ-PrNML
005      
20180515103712.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/annrheumdis-2016-210960 $2 doi
035    __
$a (PubMed)28630236
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Groot, Noortje $u Wilhelmina Children's Hospital, Utrecht, Netherlands. Sophia Children's Hospital, Erasmus University Medical Centre, Rotterdam, Netherlands.
245    10
$a European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative / $c N. Groot, N. de Graeff, T. Avcin, B. Bader-Meunier, P. Brogan, P. Dolezalova, B. Feldman, I. Kone-Paut, P. Lahdenne, SD. Marks, L. McCann, S. Ozen, C. Pilkington, A. Ravelli, AV. Royen-Kerkhof, Y. Uziel, B. Vastert, N. Wulffraat, S. Kamphuis, MW. Beresford,
520    9_
$a Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially life-threatening autoimmune disorder with significant associated morbidity. Evidence-based guidelines are sparse and management is often based on clinical expertise. SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) was launched to optimise and disseminate management regimens for children and young adults with rheumatic diseases like cSLE. Here, we provide evidence-based recommendations for diagnosis and treatment of cSLE. In view of extent and complexity of cSLE and its various manifestations, recommendations for lupus nephritis and antiphospholipid syndrome will be published separately. Recommendations were generated using the EULAR (European League Against Rheumatism) standard operating procedure. An expert committee consisting of paediatric rheumatologists and representation of paediatric nephrology from across Europe discussed evidence-based recommendations during two consensus meetings. Recommendations were accepted if >80% agreement was reached. A total of 25 recommendations regarding key approaches to diagnosis and treatment of cSLE were made. The recommendations include 11 on diagnosis, 9 on disease monitoring and 5 on general treatment. Topics included: appropriate use of SLE classification criteria, disease activity and damage indices; adequate assessment of autoantibody profiles; secondary macrophage activation syndrome; use of hydroxychloroquine and corticosteroid-sparing regimens; and the importance of addressing poor adherence. Ten recommendations were accepted regarding general diagnostic strategies and treatment indications of neuropsychiatric cSLE. The SHARE recommendations for cSLE and neuropsychiatric manifestations of cSLE have been formulated by an evidence-based consensus process to support uniform, high-quality standards of care for children with cSLE.
650    _2
$a mladiství $7 D000293
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a dítě $7 D002648
650    _2
$a Evropa $7 D005060
650    _2
$a medicína založená na důkazech $x normy $7 D019317
650    _2
$a lidé $7 D006801
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a systémový lupus erythematodes $x diagnóza $x terapie $7 D008180
650    12
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a de Graeff, Nienke $u Wilhelmina Children's Hospital, Utrecht, Netherlands.
700    1_
$a Avcin, Tadej $u University Children's Hospital Ljubljana, Ljubljana, Slovenia.
700    1_
$a Bader-Meunier, Brigitte $u Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
700    1_
$a Brogan, Paul $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
700    1_
$a Dolezalova, Pavla $u General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Feldman, Brian $u The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Kone-Paut, Isabelle $u Bicêtre Hospital, APHP, University of Paris Sud, Paris, France.
700    1_
$a Lahdenne, Pekka $u Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
700    1_
$a Marks, Stephen D $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
700    1_
$a McCann, Liza $u Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
700    1_
$a Ozen, Seza $u Department of Pediatrics, Hacettepe University, Ankara, Turkey.
700    1_
$a Pilkington, Clarissa $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
700    1_
$a Ravelli, Angelo $u Università degli Studi di Genova and Istituto Giannina Gaslini, Genoa, Italy.
700    1_
$a Royen-Kerkhof, Annet van $u Wilhelmina Children's Hospital, Utrecht, Netherlands.
700    1_
$a Uziel, Yosef $u Meir Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
700    1_
$a Vastert, Bas $u Wilhelmina Children's Hospital, Utrecht, Netherlands.
700    1_
$a Wulffraat, Nico $u Wilhelmina Children's Hospital, Utrecht, Netherlands.
700    1_
$a Kamphuis, Sylvia $u Sophia Children's Hospital, Erasmus University Medical Centre, Rotterdam, Netherlands.
700    1_
$a Beresford, Michael W $u Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 76, č. 11 (2017), s. 1788-1796
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28630236 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103846 $b ABA008
999    __
$a ok $b bmc $g 1300161 $s 1013377
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 76 $c 11 $d 1788-1796 $e 20170619 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace